Burning Rock Biotech (BNR) Operating Margin (2020 - 2025)
Historic Operating Margin for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to 12.26%.
- Burning Rock Biotech's Operating Margin rose 177400.0% to 12.26% in Q3 2025 from the same period last year, while for Sep 2025 it was 22.97%, marking a year-over-year increase of 633400.0%. This contributed to the annual value of 69.32% for FY2024, which is 552200.0% up from last year.
- As of Q3 2025, Burning Rock Biotech's Operating Margin stood at 12.26%, which was up 177400.0% from 7.74% recorded in Q2 2025.
- Burning Rock Biotech's Operating Margin's 5-year high stood at 7.74% during Q2 2025, with a 5-year trough of 202.9% in Q2 2022.
- Over the past 5 years, Burning Rock Biotech's median Operating Margin value was 135.09% (recorded in 2021), while the average stood at 112.57%.
- Its Operating Margin has fluctuated over the past 5 years, first crashed by -904600bps in 2021, then surged by 1101600bps in 2024.
- Burning Rock Biotech's Operating Margin (Quarter) stood at 171.11% in 2021, then increased by 11bps to 152.88% in 2022, then grew by 10bps to 137.37% in 2023, then soared by 53bps to 65.01% in 2024, then soared by 81bps to 12.26% in 2025.
- Its Operating Margin was 12.26% in Q3 2025, compared to 7.74% in Q2 2025 and 11.41% in Q1 2025.